<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>There is significant interest in the development of new drugs to treat vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>However, before US approval of new drugs for this entity is possible, certain issues with regulatory implications need to be addressed </plain></SENT>
<SENT sid="2" pm="?"><plain>Is vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> a distinct clinical syndrome with valid diagnostic criteria </plain></SENT>
<SENT sid="3" pm="?"><plain>Can this entity be distinguished from <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD) and other causes of <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="4" pm="?"><plain>What design features are important for clinical trials in this disorder </plain></SENT>
<SENT sid="5" pm="."><plain>The US Food and Drug Administration (FDA) convened a special meeting of the Peripheral and Central <z:mp ids='MP_0008912'>Nervous</z:mp> System Advisory Committee in an attempt to answer these questions </plain></SENT>
<SENT sid="6" pm="."><plain>The conclusions from this meeting indicate that vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VaD) is a pathologically <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> disorder but appears to be reasonably distinguishable from AD <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>The NINDS-AIREN diagnostic criteria are suitable as entry criteria for vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> trials </plain></SENT>
<SENT sid="8" pm="."><plain>Trials should be similar in duration to AD <z:hpo ids='HP_0000726'>dementia</z:hpo> trials and should employ a dual outcome strategy (cognitive + global/functional measures) </plain></SENT>
<SENT sid="9" pm="."><plain>For drugs that are believed to have a disease-modifying effect, clinical trials should study specific vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> subtypes and would need to employ substantially different designs from those used currently </plain></SENT>
<SENT sid="10" pm="."><plain>The term "vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>" may not be entirely appropriate to describe this population </plain></SENT>
</text></document>